Antiarrhythmic drugs for atrial fibrillation in the outpatient setting

被引:0
|
作者
Tseng, Andrew S. [1 ]
Desimone, Christopher V. [1 ]
Kowlgi, Gurukripa N. [1 ]
机构
[1] Mayo Clin, Dept Cardiovas Med, Rochester, MN USA
关键词
Atrial fibrillation; Cardiac arrhythmias; Outpatients; DIRECT ORAL ANTICOAGULANTS; HEART-FAILURE; DIGOXIN; DRONEDARONE; CAFFEINE; RISK; METAANALYSIS; ASSOCIATION; ARRHYTHMIAS; DOFETILIDE;
D O I
10.23736/S0026-4806.23.08524-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With burgeoning evidence for early rhythm control in patients with atrial fibrillation (AF), the management of AF in the outpatient setting has become more challenging. The primary care clinician often serves as the frontline in the pharmacologic management of AF. Because of drug interactions and the risk of proarrhythmia, many clinicians remain hesitant about the initiation and chronic management of antiarrhythmic drug prescriptions. However, with the likely increased use of antiarrhythmics for early rhythm control, understanding and familiarity with these medications have likewise become more important, especially since patients with AF probably have other non-cardiac medical conditions that can impact their antiarrhythmic therapy. In this comprehensive review, we provide informative, high-yield cases and edifying references that will help primary care providers become comfortable handling various clinical scenarios.
引用
收藏
页码:839 / 849
页数:11
相关论文
共 50 条
  • [21] Prevention of atrial fibrillation using antiarrhythmic drugs postcardioversion of new onset atrial fibrillation
    Li, HG
    Riedel, R
    Oldemeyer, B
    Wurdman, R
    Rovang, K
    Hee, T
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 82A - 82A
  • [22] Atrial fibrillation. New anticoagulants and antiarrhythmic drugs
    Kaya, E.
    Frommeyer, G.
    Moennig, G.
    Eckardt, L.
    HERZ, 2012, 37 (02) : 159 - 163
  • [23] Comparing antiarrhythmic drugs in preventing atrial fibrillation recurrence
    Papavasileiou, L. P.
    Santini, L.
    Panella, A.
    Sgueglia, M.
    Di Battista, L. E.
    Romano, V.
    Magliano, G.
    Borzi, M.
    Romeo, F.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2007, 18 : S23 - S23
  • [24] COMPARATIVE EFFECTS OF ANTIARRHYTHMIC DRUGS IN ATRIAL-FIBRILLATION
    MOKRAOUI, AM
    FRIEDMAN, HS
    NGUYEN, TN
    MANYARJI, N
    OCONNOR, D
    STERMAN, H
    MELNIKER, L
    CLINICAL RESEARCH, 1985, 33 (03): : A745 - A745
  • [25] ANTIARRHYTHMIC DRUGS - USE OF QUINIDINE IN ATRIAL-FIBRILLATION
    SIMON, AP
    JOURNAL OF THE KANSAS MEDICAL SOCIETY, 1977, 78 (01): : 18 - &
  • [26] Impact of Antiarrhythmic Drugs on a Virtual Model of Atrial Fibrillation
    Wilhelms, M.
    Holl, L. P.
    Doessel, O.
    Seemann, G.
    BIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK, 2012, 57 : 788 - 788
  • [27] ANTIARRHYTHMIC DRUGS VS. ABLATION FOR ATRIAL FIBRILLATION
    Irfan, Ghazala
    PAKISTAN HEART JOURNAL, 2023, 56 (02): : 191 - 192
  • [28] Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
    Dan, Gheorghe-Andrei
    Dobrev, Dobromir
    IJC HEART & VASCULATURE, 2018, 21 : 11 - 15
  • [29] Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil
    Krishnamoorthy, Suresh
    Lip, Gregory Y. H.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (08) : 1191 - 1196
  • [30] Non-Antiarrhythmic Drugs to Prevent Atrial Fibrillation
    Moro, Concepcion
    Hernandez-Madrid, Antonio
    Matia, Roberto
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2010, 10 (03) : 165 - 173